# Pulmonary diseases Task Force Refined phenotypes The files contains curated phenotypes for asthma severity and asthma/COPD overlap (ACO). Asthma severity has been estimated based on the drug purchases (specific drugs and doses are shown in the end of the document) for each month of the follow-up period (ERS/ATS 2014 criteria): * gina\_classification\_max: dDtermine each patient’s highest GINA class and the duration they have continuously remained in that class. * gina\_classification\_max\_GINA5\_GINA4\_CONT\_TRANS: Identify each patient’s highest GINA class in which they have remained continuously for at least one year. * gina\_classification\_longitudinal\_eras: GINA eras * gina\_classification\_longitudinal\_monthly: Raw data’, GINA class for each month of the follow-up \ ACO phenotype contains individuals with the overlap of asthma and chronic obstructive pulmonary disease. The data is available in the following Sandbox directory: `/finngen/library-red/task_force_data/Pulmonary/Refined_phenotypes/` ### File structure #### **Severe asthma** Data is in four files: **Pulmonary\_task\_force\_gina\_classification\_max.txt.gz** 41200 rows and 41200 unique FINNGENIDs Group\_name: Highest Global Initiative for Asthma (GINA) classification (GINA0-5) attained by the patient during follow-up. Time\_type: 1\. GINA class kept continuously period of > 4 years 2\. GINA class kept continuously period of 1-4 years 3\. GINA class kept continuously period <1 year **Pulmonary\_task\_force\_gina\_classification\_longitudinal\_eras.txt.gz** 379096 rows and unique 44480 FINNGENIDs gina\_step: Gina step/class from 0 to 5 start\_month: start month of the GINA era end\_month: end month of the GINA era **Pulmonary\_task\_force\_gina\_classification\_longitudinal\_monthly.txt.gz** 8060435 rows and unique 44480 FINNGENIDs month: number of the follow-up month gina\_step: Gina step/class 0-5 of the month **Pulmonary\_task\_force\_gina\_classification\_max\_GINA5\_GINA4\_CONT\_TRANS.txt**\ 18403 rows and unique 18403 FINNGENIDs Maximum GINA Class kept continuously a period of >1 year #### **Data specifics** Asthma severity (based on medication): • Severe asthma: ERS/ATS 2014 criteria (dispensing of ICS ≥ 1600 ug budesonide daily) and at least one dispensed second controller (LTRA, LABA, LAMA, theophylline) during the same year • GINA step 4/5 asthma (accoding to newest/most relevant GINA guideline) and at least one dispensed second controller (LTRA, LABA, LAMA, theophylline) during the same year • Control groups for severe asthma groups: non-severe asthma GINA groups 0-3 and healthy controls (no obstructive lung disease) #### **ACO Data** | File | Description | | ----------------------------------------- | ------------------------------------ | | PULMONARY\_TASK\_FORCE\_ACO\_CASES.tsv.gz | Cases with Asthma-COPD overlap (ACO) | #### Phenotype definitions | Phenotype | Criteria | | --------------- | ------------------------------------------------------------------------------- | | **Asthma** | Any of: ICD10: J45-J46, J82; ICD9: 493; ICD8: 493 | | **COPD** | Any of: ICD10: J41-J44; ICD9: 491, 492, 496; ICD8: 49104, 492 | | **ACO (Cases)** | Individuals given both diagnoses by a physician at least once during follow-up. | | **CONTROL** | No diagnosis of Asthma, COPD, or Alpha-1 antitrypsin deficiency. | #### Exclusions (Cases and Controls) Individuals with the following conditions were excluded from both case and control groups: * **Alpha-1 antitrypsin deficiency** * **ICD-10:** E88.0, E88.01, E88.9 * **ICD-9:** 273.4 #### Diagnosis Date For ACO cases, the "Diagnosis Date" indicates the specific date when the person has satisfied the criteria for both asthma and COPD (i.e., the date of the second occurring diagnosis type).